⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2024Open Access

Table S11 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study

Yann Ruffieux Nathalie V. Fernández Villalobos Christiane Didden Andreas D. Haas Chido Chinogurei Morna Cornell Matthias Egger Gary Maartens Naomi Folb Eliane Rohner

View Full Paper

Ask AI

Bookmark

Share

Abstract

Table S11 shows hazard ratios for prostate cancer diagnosis, restricting to men with an elevated prostate specific antigen test result (>4 ng/mL) followed by a prostate biopsy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ruffieux et al. (2024) studied this question.

synapsesocial.com/papers/68e5e0e0b6db643587574b9f https://doi.org/10.1158/1055-9965.26424010

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S11 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
2Table S10 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
3Table S10 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
4Table S12 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
5Table S12 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024

Table S8 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
Table S8 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
Table S6 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024